Craneware plc

Equities

CRW

GB00B2425G68

Software

Delayed London S.E. 09:22:11 2024-04-25 am EDT 5-day change 1st Jan Change
2,279 GBX -0.48% Intraday chart for Craneware plc +1.74% +30.23%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Craneware extends share buyback scheme again by three months AN
Craneware plc's Equity Buyback Plan Extended till July 17, 2024. CI
Craneware profit rises on higher sales; set to meet expectations AN
Jefferies says buy BP; UBS says buy Compass AN
Craneware Posts Higher Fiscal H1 Attributable Profit, Revenue MT
Earnings Flash (CRW.L) CRANEWARE Reports Fiscal H1 Revenue $91.2M MT
Earnings Flash (CRW.L) CRANEWARE Posts Fiscal H1 EPS $0.115 MT
Craneware plc Declares Dividend, Payable on April 15, 2024 CI
Craneware plc Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Craneware in "strong position" after solid six-month performance AN
Craneware Returns to Adjusted EPS Growth in Fiscal H1, Revenue Rises MT
Craneware plc's Equity Buyback Plan Extended till April 17, 2024. CI
FTSE 100 Closes Down 1% as Oil, Mining Stocks Weigh DJ
Craneware enjoys positive start as tracks in line with expectations AN
Craneware extends share buyback programme until January AN
Craneware plc's Equity Buyback Plan Extended till January 17, 2024. CI
Craneware posts an annual surge in revenue but says profit flat AN
Craneware FY23 Attributable Profit Edges Down; Revenue Jumps MT
Earnings Flash (CRW.L) CRANEWARE Posts FY23 Revenue $174M MT
Earnings Flash (CRW.L) CRANEWARE Posts FY23 EPS $0.26 MT
Tranche Update on Craneware plc's Equity Buyback Plan announced on April 12, 2023. CI
Craneware plc Proposes Final Dividend for the Year Ended 30 June 2023, Payable on 15 December 2023 CI
Craneware plc Reports Earnings Results for the Full Year Ended June 30, 2023 CI
FTSE 100 Closes Monday Down 0.4% Dragged by Miners DJ
UK Finance Chiefs Are More Gloomy About Outlook DJ
Chart Craneware plc
More charts
Craneware plc is a United Kingdom company that is engaged in the development, licensing, and ongoing support of computer software for the United States healthcare industry. Its value cycle insights are delivered through its Trisus platform for revenue integrity and 340B management, as well as margin and operational intelligence. Its applications and team of experts contextualize operational, financial, and clinical data, providing insights that clearly demonstrate realistic revenue integrity and 340B compliance opportunities for its customers. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Healthcare Intelligence, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Sentrex 330, Referral Verification System (Sentrex), Referral Verification System (Senturion), Sentry Core, Senturion Professional Service and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
28.47 USD
Average target price
33.79 USD
Spread / Average Target
+18.70%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRW Stock
  4. News Craneware plc
  5. Craneware to Sustain Strong Performance Amid 'High' Sales Activity